How a treatment using laboratory-made antibodies could fight Covid-19.
Related News
Covid-19: IAVI, Merck, Serum join hands to develop monoclonal antibodies
IAVI, a non-profit scientific research organisation dedicated to addressing urgent and unmet global health challenges, and Pune-based Serum Institute of India Pvt Ltd, have...
Business Line 2020-10-22Eli Lilly monoclonal antibody drug trial paused over safety concerns
(Natural News) Eli Lilly & Company are halting the enrollment of participants in a clinical trial of its antibody treatment for the Wuhan...
Natural News 2020-10-20IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 ...
PUNE, India & NEW YORK--(BUSINESS WIRE)--IAVI and Serum Institute of India to partner with Merck on monoclonal antibody development for globally accessible treatment of...
Business Wire 2020-10-22Eli Lilly pauses trial of antibody
DRUGMAKER Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons. Usually, clinical trials are paused because...
Shenzhen Daily 2020-10-21Adaptive Biotech CEO says it’s working to develop the best antibody treatment for Covid-19
Adaptive biotechnologies CEO Chad Robins says the company is working night and day to develop an effective...
CNBC 2020-10-22AVI, Merck and Serum Institute join forces to develop monoclonal antibodies for Covid-19 response
The International AIDS Vaccine Initiative (IAVI), a non-profit scientific research organisation dedicated to addressing urgent global health challenges, and Serum Institute...
Indian Express 2020-10-22Antibody Discovery Services and Platforms Market, 2030 - 80 Monoclonal Antibodies Approved to Date & 550+ Molecules in the Clinical Pipeline
DUBLIN, Oct. 21, 2020 /PRNewswire/ -- The "Antibody Discovery Services and Platforms Market (3rd Edition) by Service Offered, by Antibody Discovery Method, by Nature of...
PR Newswire 2020-10-21